跳至主要内容
临床试验/NCT02492243
NCT02492243已完成2 期

Continuous Rhythm Monitoring in Patients After Acute Myocardial infaRction and pREServed Left venTricle Ejection Fraction

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Ventricular fibrillation

研究概览

简要总结

The trial will inform whether detection of ventricular arrhythmias by means of implantable loop recorder (ILR) can help to predict SCD in the large population of survivors of a myocardial infarction with preserved left ventricular function, EF>40%. This may improve risk stratification in these patients, and can inform on the clinical use of subcutaneous monitors to identify post-infarction populations in need for an intervention to prevent sudden death.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent signed
  • Documented myocardial infarction in the 7days prior to enrolment
  • Age > 18 yrs
  • Left ventricular ejection fraction >=40% as assessed by echocardiography within 7 days window after MI.

排除标准

  • subject is unwilling or unable to comply with the study procedures
  • documented ventricular tachycardia or survived cardiac arrest outside of an acute coronary syndrome
  • Subject has indications for active implanted cardiac medical device (IPG, ICD, CRT).
  • contraindications for implantation of a ICM - Planned CABG procedure

结局指标

主要结局

Ventricular fibrillation

时间窗: 24 months

Cardiac arrest

时间窗: 24 months

Documented Arrhythmic death without evidence of primary non cardiac cause

时间窗: 24 months

Sustained, nonsustained, symptomatic, asymptomatic ventricular tachycardias

时间窗: 24 months

Atrial Fibrillation (symptomatic and asymptomatic)

时间窗: 24 months

次要结局

  • Changing in treatment strategy, based on physician decision(24 months)
  • CV events(24 months)
  • Invasive procedures for arrhythmia treatment(24 months)
  • All Arrhythmic events recorded by ILR(24 months)
  • Changing in medical treatment (anticoagulation, antiarrhythmic drugs)(24 months)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验